TweenVax Study aims to improve HPV vaccination rates among adolescents. Human papillomavirus (HPV) is a virus that can lead to certain types of cancer. Vaccinating kids by age 13 can help prevent these cancers. However, only about 16% of kids are currently vaccinated by this age. The study will test a new educational tool called TweenVax, which provides information to doctors, parents, and kids about the importance of HPV vaccination. Participants are divided into three groups:
- Group 1: Receives full TweenVax training and access to an app during doctor visits.
- Group 2: Receives some training, but not the app.
- Group 3: Gets standard vaccination info.
Pediatric practices will use these methods for about 9 months and will be monitored for 1 year. To join, practices must be community-based, use digital records, and have enough patients aged 9-12 who haven't started the HPV vaccine series.
- Key Points: Study lasts for up to 1 year after interventions.
- Participants include practices that see 51 kids ages 9-12 over 9 months.
- Involves new educational tools for better vaccine discussions.
How understandable was the trial content above?
Hard to understand
Easy to understand